Increasing HDL-cholesterol levels with phenylethylamine derivatives
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 18, 1984
Grant Date -
N/A
app pub date -
Dec 6, 1982
filing date -
Dec 6, 1982
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
High density lipoprotein (HDL) levels in serum cholesterol are increased by orally administering phenylethylamine derivatives having the structural formula ##STR1## wherein R.sub.1 is a member selected from the group consisting of --CH(CH.sub.3).sub.2, --C(CH.sub.3).sub.3 and ##STR2## R.sub.2 is a member selected from the group consisting of --OH and --CH.sub.2 OH; and R.sub.3 and R.sub.4, respectively, are members selected from the group consisting of --H and --OH.
First Claim
Family
International Classification(s)
- Non-US Classification not provided for expired patents
Cited Art Landscape
Patent Citation Ranking
- Citation Ranking not provided for expired patents
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully